Patients with hyperammonemia that have clinical signs and symptoms of lysinuric protein intolerance mitochondrial disorders congenital lactic acidosis and fatty acid oxidation disorders patients with rare and unrelated serious comorbidities and other genetic diseases e.g. Down syndrome intraventricular hemorrhage in the newborn period traumatic brain injury and low birth weight 2,200 g at 36 wks gestation 